Vivan Therapeutics — investors & funding

Investors

5 investors

All

Early stage

Mid stage

Late stage

Seed investors· 1

Dr. Priyanka Kedia Goel

Medical Doctor and Angel Investor specializing in healthcare biotechnology and therapeutics, with over 20 years of expertise in leading healthcare sectors in Chicago and New York and London.

Primary Pre Seed Investor

Angel investors· 1

Co-founder @ Sky Valley Ambient Computing | Building Differ | Adaptive Software

Mid stage· 3

Chief of Staff @ AI Safety (launching August) | Co-founder @ Psychedelic Action Task Force | Award-winning campaigner against FGM + VAWG | ex-Slaughter and May

Healthtech Investor | Primary Care Accelerator | Scaled in the NHS | NED

Co-founder | CEO Synteny

Investor geography1 country

United Kingdom

Investor activity2018–2024 · investors recorded per year

Recent (last 2y)Earlier

Frequently asked questions

Who invested in Vivan Therapeutics?

Vivan Therapeutics has 5 investors on record on gritt.io, including 1 early-stage backers, 3 mid-stage and 1 late-stage investors.

When did Vivan Therapeutics last raise funding?

The most recent investment in Vivan Therapeutics recorded on gritt.io was in December 2024.

When was Vivan Therapeutics founded?

Vivan Therapeutics was founded in 2018.

What industry is Vivan Therapeutics in?

Vivan Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.

Where is Vivan Therapeutics based?

Vivan Therapeutics is headquartered in London, United Kingdom.